Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration

Field Value
Model ID12-034-02
Model NameWang 2012 - 1 Year Imminent Death
Pubmed ID22819429
First AuthorWang
JournalAmerican Journal of Cardiology
Year2012
TitlePredicting risk of hospitalization or death among patients with heart failure in the veterans health administration
Primary Index ConditionChronic Heart Failure (CHF)
Secondary Index ConditionN/A
OutcomeMortality
Model Sample Size198640
Cohort Sample Size198640
Number of Events14103
Follow-Up DurationLong (>6 months)
AUROC0.758
Calibration Reported1
CovariatesAge (years) 18-55; Age (years) 55-65; Age (years) 65-75; Age (years) 75-80; Age (years) 80-85; Age (years) >85; Male vs female; Married currently; Service connection >=50% vs <50%; VA priority groups 1 vs 6 to 8; VA priority groups 2,3 vs 6 to 8; VA priority groups 4 vs 6 to 8; VA priority groups 5 vs 6 to 8; Age >=65 years; Deyo-Charlson Index; Age 65 * Deyo-Charlson; Myocardial infarction (MI); CABG; MI * CABG; Unstable angina pectoris; Respiratory failure; Valvular heart disease; Respiratory failure * valvular heart disease; Renal failure; Chronic obstructive pulmonary diseases (COPD); Renal failure * COPD; Dementia; Renal failure * dementia; Hospitalized in the prior year; Hospitalized * valvular heart disease; Stroke; Hospitalized * stroke; Renal failure * stroke; Function disease; COPD * dementia; Pneumonia; Diabetes; Malnutrition; Peripheral vascular disease; Metastatic cancer; Trauma; Hospitalized * trauma; Psychotic disorder; Liver disease; Atrial fibrillation; Mental disorder; Systolic blood pressure 110-140 vs <110; Systolic blood pressure >140 vs <110; Diastolic blood pressure 60-89 vs <60; Diastolic blood pressure >=90 vs <60; Heart rate 60-85 vs <60; Heart rate >85 vs <60; Respiration 18-20 vs <18; Respiration >20 vs <18; Body mass index (BMI) 25-29 vs <25; BMI 29-35 vs <25; BMI 35+ vs <25; BMI missing vs <25; Emergency visits (1 year): 1 vs 0; Emergency visits (1 year): 2 vs 0; Emergency visits (1 year): 3,4 vs 0; Emergency visits (1 year): 5+ vs 0; Primary care visits (1 year): 1,2 vs 0; Primary care visits (1 year): 3,4 vs 0; Primary care visits (1 year): 5+ vs 0; Cardiology visits (1 year): 1+ vs 0; Pulmonary visits (1 year): 1+ vs 0; Mental health visits (1 year): 1-3 vs 0; Mental health visits (1 year): 4+ vs 0; Phone visits (1 year): 1-3 vs 0; Phone visits (1 year): 4+ vs 0; Other nonface visits (1 year): 1,2 vs 0; Other nonface visits (1 year): 3-9 vs 0; Other nonface visits (1 year): 10-15 vs 0; Other nonface visits (1 year): 16+ vs 0; Other visits (1 year): 1-3 vs 0; Other visits (1 year): 4-9 vs 0; Other visits (1 year): 10-29 vs 0; Other visits (1 year): 30+ vs 0; Outpatient visits (1 year): 6-10 vs 0-5; Outpatient visits (1 year): 11-19 vs 0-5; Outpatient visits (1 year): 20-29 vs 0-5; Outpatient visits (1 year): 30+ vs 0-5; Emergency visits (1 month): 1+ vs 0; Cardiology visits (1 month): 1+ vs 0; Other nonface (1 month): 1 vs 0; Other nonface (1 month): 2+ vs 0; Other visits (1 month): 1 vs 0; Other visits (1 month): 2+ vs 0; Outpatient visits (1 month): 1 vs 0; Outpatient visits (1 month): 2 vs 0; Outpatient visits (1 month): 3+ vs 0; Mental health hospitalizations (1 year): 1+ vs 0; All hospitalizations (1 year): 1 vs 0; All hospitalizations (1 year): 2 vs 0; All hospitalizations (1 year): 3 vs 0; All hospitalizations (1 year): 4 vs 0; All hospitalizations (1 year): 5+ vs 0; Number providers: 2 vs 1; Number providers: 3,4 vs 1; Number providers: 5,6 vs 1; Number providers: 7+ vs 1; Number of refills: 1-14 vs 0; Number of refills: 15-22 vs 0; Number of refills: 23-31 vs 0; Number of refills: 32-45 vs 0; Number of refills: 46+ vs 0; ACEI/ARB; Hospitalized * ACEI/ARB; Alpha-blockers; Anticholinergics; Antidepressants; Antipsychotics; Benzodiazepines; Beta agonists; Beta blockers; Hospitalized * Beta blockers; Bumetanide; Digoxin; Furosemide; Statins; Insulin; Metformin; Metolazone; Hospitalized * metolazone; Nitrates; Opioid narcotics; Hospitalized * opioid narcotics; Age 65 * opioid narcotics; Non-steroidal anti-inflammatory drugs (NSAID); Age 65 * NSAID; Thiazolidenediones; Potassium-sparing diuretic; Oral steroids; Diuretic combinations; Torsemide; Warfarin; No laboratory test in last year; Albumin (g/dL): 2.5-3.5 vs >=3.5; Albumin (g/dL): <2.5 vs >=3.5; Albumin not tested vs >=3.5; Blood urea nitrogen (mg/dL): 17-25 vs <17; Blood urea nitrogen (mg/dL): 25-40 vs <17; Blood urea nitrogen (mg/dL): >40 vs <17; Blood urea nitrogen not tested vs. <17; Creatinine (mg/dL): 1.2-2 vs <1.2; Creatinine (mg/
Mesh TermsTo be updated
Number of Validations0

External Validations